| Pharmaceutical active ingredients: |
| GlyburideMetformin Hydrochloride |
| Available forms, composition and doses of Norfaben M: |
| Tablets; Oral; Glyburide 2.5 mg; Metformin Hydrochloride 500 mgTablets; Oral; Glyburide 5 mg; Metformin Hydrochloride 500 mg |
| Norfaben M medical category: |
| Human:Antidiabetic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BB01 - GlibenclamideA10BD02 - Metformin and sulfonamides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pisa Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Isloglib | Glyburide; Metformin Hydrochloride | Craveri |
| Kontroger | Glyburide; Metformin Hydrochloride | Streger |
| Metixor G | Glyburide; Metformin Hydrochloride | Landsteiner Scientific |
| Midapharma | Glyburide; Metformin Hydrochloride | Psicofarma Laboratorio |
| Mydiatab | Glyburide; Metformin Hydrochloride | Hainan HealthCare Laboratories; HealthCare PharmaScience; Via Hong |
| Normell | Glyburide; Metformin Hydrochloride | Sanofi-Aventis |
| Suguan M | Glyburide; Metformin Hydrochloride | Sanofi-Aventis |
| Wadil | Glyburide; Metformin Hydrochloride | Biomep |
| Triglycomet | Glyburide; Metformin Hydrochloride; Pioglitazone | USV, India |
| Iscept-P | Glyburide; Metformin; Pioglitazone | Grandix Pharmaceuticals |